Back

Longitudinal trends in statin prescribing and LDL-C control prior to acute myocardial infarction (AMI) in France: we continue to “miss the mark”

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Lipid lowering (2) Drug therapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Pierre-Guillaume PIRIOU

Bichat University Hospital, APHP, Universite Paris-Cite, FACT Network, Paris (France)

5 More presentations in this session

Presentation thumbnail
Sex- and age-based disparities in statin use in patients admitted for acute myocardial infarction in France: two decades of failure ?
Doctor P. PIRIOU (Paris, FR)
Abstract Slides
Presentation thumbnail
Association between remnant cholesterol levels and the in-hospital outcomes and long-term prognosis in ST-segment elevated myocardial infarction patients
Ms H. Chen (CN)
Abstract Slides
Presentation thumbnail
Aspirin for primary prevention in patients with diabetes according to lipoprotein(a) levels: a real-world propensity-matched analysis
Doctor A. Askarinejad (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Intensive lipid lowering therapy improves microvascular function assessed by retinal vessel analysis in patients after ST-elevation myocardial infarction
Doctor D. Hanke (Jena, DE)
Abstract Slides
Presentation thumbnail
Changes in lipoprotein(a) levels in younger patients following ST-elevation myocardial infarction
Doctor J. Yoon (Vancouver, CA)
Abstract Slides

Access the full session

Session thumbnail
Lipid lowering (2)

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Missed opportunity in primary prevention: an analysis of acute myocardial infarction patients with no history of atherosclerotic cardiovascular disease
31 August 2025
thumbnail
Congress Presentation
LDL-cholesterol levels post-acute coronary syndrome: 24-months variation
4 April 2025
thumbnail
Congress Presentation
Cross-sectional analysis of primary PCI provision and AMI mortality across europe: accounting for economic and disease burden
20 February 2026
thumbnail
Congress Presentation
Time trends in risk factor control and use of secondary preventive medication among patients with myocardial infarction attending cardiac rehabilitation: data from the SWEDEHEART registry 2006-2017
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources